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Abstract
The H1N1 influenza A virus of swine-origin caused pandemics throughout the world in 2009 and the highly pathogenic
H5N1 avian influenza virus has also caused epidemics in Southeast Asia in recent years. The threat of influenza A thus
remains a serious global health issue and novel drugs that target these viruses are highly desirable. Influenza A possesses an
endonuclease within its RNA polymerase which comprises PA, PB1 and PB2 subunits. To identify potential new anti-
influenza compounds in our current study, we screened 33 different types of phytochemicals using a PA endonuclease
inhibition assay in vitro and an anti-influenza A virus assay. The marchantins are macrocyclic bisbibenzyls found in
liverworts, and plagiochin A and perrottetin F are marchantin-related phytochemicals. We found from our screen that
marchantin A, B, E, plagiochin A and perrottetin F inhibit influenza PA endonuclease activity in vitro. These compounds have
a 3,4-dihydroxyphenethyl group in common, indicating the importance of this moiety for the inhibition of PA endonuclease.
Docking simulations of marchantin E with PA endonuclease suggest a putative ‘‘fitting and chelating model’’ as the
mechanism underlying PA endonuclease inhibition. The docking amino acids are well conserved between influenza A and B.
In a cultured cell system, marchantin E was further found to inhibit the growth of both H3N2 and H1N1 influenza A viruses,
and marchantin A, E and perrotein F showed inhibitory properties towards the growth of influenza B. These marchantins
also decreased the viral infectivity titer, with marchantin E showing the strongest activity in this assay. We additionally
identified a chemical group that is conserved among different anti-influenza chemicals including marchantins, green tea
catechins and dihydroxy phenethylphenylphthalimides. Our present results indicate that marchantins are candidate anti-
influenza drugs and demonstrate the utility of the PA endonuclease assay in the screening of phytochemicals for anti-
influenza characteristics.
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Introduction
An influenza A pandemic in 1918, known as the Spanish flu,
caused 50 million deaths worldwide [1–3]. More recently, the
avian H5N1 influenza A virus, which is highly pathogenic to
humans, caused epidemics in Southeast Asia [4] and a new strain
(Pandemic (H1N1) 2009) that emerged from pigs into humans
caused a further pandemic in 2009 [5,6]. Strategies are thus
needed to prevent future expansions of these viruses which remain
a serious global health issue. Although neuraminidase inhibitors
such as oseltamivir are widely used as anti-influenza drugs [7,8],
some side effects of these agents and also the emergence of viral
strains that are resistant to these agents have now been reported
[9–11]. For the future prevention and control of influenza
outbreaks, it will therefore be critical to develop novel drugs that
are not based on neuraminidase inhibition.
The influenza A genome consists of segmented single stranded
RNA (-) and its transcription and replication require the activity of
a highly conserved RNA-dependent RNA polymerase [12–14].
The influenza A RNA-dependent RNA polymerase is composed
of three subunits, PA, PB1 and PB2, and synthesizes viral mRNAs
using short capped primers derived from host cellular mRNAs that
are cleaved by the viral endonuclease [12,13]. Yuan et al. and Dias
et al. have shown previously that the N-terminal domain of the PA
subunit contains a typical endonuclease active site and also
harbors RNA/DNA endonuclease activity [15–17]. This domain
is essential for viral growth and we speculated that it would be a
highly effective target domain to which novel anti-influenza A
drugs would bind.
The Marchantiophyta liverworts and several other types
produce a large number of various lipophilic terpenoids, sesqui-
and diterpenoids, phenolics [18–28], bibenzyls and bisbibenzyls
[21–28]. Marchantin (Fig. 1), a unique macrocyclic structure
denoted as a cyclic bisbibenzyl, is a phytochemical found in several
liverworts. The yield of marchantin A (MA) is extremely high (a
100–120 gram quantity can be obtained from 2 kg of dried
material), for the Japanese Marchantia poleacea var. diptera.
Marchantins A (MA), B (MB), C (MC) and E (ME) and
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riccarrdin A (RA) from Riccardia multifida, ptychantol A (PtA) from
Ptychanthus striatus, plagiochin A (PlA) from Plagiochila fruticosa, all of
which are marchantin-like phytochemicals, have one or two diaryl
ether or biphenyl bonds (Fig. 1). The bisbibenzyl, perrottetin F
(PeF), isolated from Lunularia cruciata is also similar to marchantin
but is not cyclic (Fig. 1) [18–23]. These compounds have shown
interesting biological activities in the past such as cytotoxicity, 5-
lipoxygenase inhibitory activity, inhibitory activity against NO
production stimulated by lipopolysaccharide (LPS), antimicrobial
activity, antitumor activity, and farnesoid X receptor (FXR)-
activating activity, among others [24,25].
In our current study, we screened 33 different phytochemicals
using PA endonuclease in vitro and then examined the anti-
influenza activities of these selected compounds. Marchantin and
other phytochemicals (Fig. 1) were purified as previously described
[18–28]. We performed initial in vitro screenings for the inhibition
of PA endonuclease activity. After this in vitro selection, we
performed an anti-virus assay. We found from these analyses that
marchantins and related chemicals inhibit PA endonuclease
activity, and exert anti-influenza activity in cultured cells and in
focus formation assays.
Results
Inhibition of PA endonuclease by marchantins
We tested 33 phytochemicals in a PA endonuclease-inhibition
assay, as shown in Figure 1, using the recombinant PA
endonuclease domain protein. In this assay, we incubated
0.1 mM of recombinant PA endonuclease domain with both 1 or
10 mM of each phytochemical. The PA endonuclease domain
digests circular single stranded DNA in vitro (Fig. 2, lanes 1 & 2)
[16,29] and we examined whether any of the phytochemicals in
our panel could inhibit this activity. Only marchantin A (MA), B
(MB), E (ME) and the marchantin-related chemicals, perrottetin F
(PeF) and plagiochin A (PlA), showed any inhibitory activity at a
10 mM concentration (Fig. 2, lanes 3, 7, 15, 17 & 21). This is the
first evidence that the phytochemicals derived from the liverwort
plant can inhibit the influenza A endonuclease. Each of the five
inhibitory compounds also contain a dihydroxyphenethyl group
(Fig. 1), which is absent from the other chemicals in the study
panel (Fig. 1), thus suggesting its importance for PA endonuclease
inhibition.
Docking simulation for marchantin with the influenza PA
endonuclease domain
To further investigate how marchantin and its related chemicals
inhibit PA endonuclease activity and why the dihydroxyphenethyl
group is important for this function, we performed in silico docking
simulation analysis of marchantin E with PA endonuclease using
tertiary structure information. The tertiary structure of PA
endonuclease has already been resolved [30] and the tertiary
structure and flexibility of marchantin E was determined in our
present study using the MOE program [31–33]. The analysis
indicated that marchantin fits well into the active pocket of PA
endonuclease (Fig. 3A, B). PA endonuclease harbors two Mn
2+
ions in its active site (Fig. 3A) [30] which are important for its
activity [15,16]. Our docking simulation experiments further
revealed that the dihydroxy group in the dihydroxyphenethyl
group of marchantin E chelates the Mn
2+ ions within PA
endonuclease (Fig. 3C). This dihydroxy group also interacts with
several active amino acids (Fig. 3C). The aromatic rings and
methoxy group of marchantin E bind to the active pocket of PA
endonuclease through a hydrophobic interaction (Fig. 3C). We
further performed docking simulation analysis of marchantin A
with PA endonuclease and the results were almost identical. This
docking analysis is consistent with our observations of endonucle-
ase inhibition, and confirms the importance of the dihydroxyphe-
nethyl group.
Inhibition of influenza A and B viruses by marchantins
Following in vitro selection using the endonuclease-inhibition
assay, as a second screening, we next examined the anti-viral
activity of MA, ME, perrottetin F and plagiochin A against the
influenza strains A/Hiroshima/52/2006 (H3N2), A/Solomon/3/
2006 (H1N1) and B/Malaysia/2506/2004. As a control, two
phytochemicals, marchantin A trimethoxy and isomarchantin C,
which do not inhibit PA endonuclease, were also examined. The
phytochemicals and viruses were mixed and then added to cultures
of Madin-Darby canine kidney (MDCK) cells [34]. As shown in
Figure 4, the blue color indicates viable cells, indicating that the
influenza virus had been inhibited [35]. Marchantin E showed the
strongest anti-influenza activity against the A/Hiroshima/52/
2006 (H3N2) and A/Solomon/3/2006 (H1N1) viruses at a 50 mM
concentration (Fig. 4A, B), and against B/Malaysia/2506/2004
virus at a 25 mM dose (Fig. 4C). Marchantin A and perrottetin F
were found to have inhibitory activity against the B/Malaysia/
2506/2004 virus at 50 mM (Fig. 4). The other compounds and
DMSO solvent alone (negative control) did not show anti-
influenza activity. All of the inhibitory phytochemicals also showed
PA endonuclease-inhibition activity and harbor a dihydroxyphe-
nethyl group within their structures. This demonstrates that the in
vitro PA endonuclease activity assay is a useful tool for the
screening of potential anti-influenza chemicals and also confirms
the importance of the dihydroxyphenethyl group for anti-influenza
activity.
To examine whether marchantins can decrease the viral
infectivity titer or not, we performed a focus-formation assay
[36] without pre-incubation prior to infection. This assay
determines viral growth in cells and can exclude the possibility
of virus-absorption effects. We counted the viral foci using the PAP
(peroxidase anti-peroxidase) method along with time course. The
raw data are shown in Table S1 and the results are summarized in
Table 1 and Figure 5. The marchantins and related chemicals
decreased viral focus-formation in a dose-dependent manner,
indicating that these compounds inhibit viral growth in host cells.
Among these chemicals, MA, ME and PeF showed the strongest
activity at 50 mM, as shown in Table 1 (highlighted in blue). MA,
ME and PeF each contain a dihydroxyphenethyl group, again
confirming the importance of this moiety. Marchantin E showed
the strongest activity (Table 1). These results are consistent with
the data shown in Figure 4.
Conserved amino acids important for docking between
influenza A and B
Since marchantin E inhibits the growth of both influenza A and
B (Fig. 4), we predicted that the amino acids in PA which are
important for binding to marchantin E should be conserved
between these virus strains. Using the clustal X program [37], we
Figure 1. Chemical structures of the phytochemicals tested in this study. Diverse chemical structures of the phytochemicals screened in this
study for their anti-influenza A activities. The sources for these structures are described in the materials and methods.
doi:10.1371/journal.pone.0019825.g001
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(Fig. 6). Glu23, His41, Glu80, Arg84, Asp108, Glu119 and Lys134
are the predicted docking amino acids as shown in Figure 2 and
are fully conserved (Fig. 6). The endonuclease-inhibition, anti-
influenza activity and docking simulation results are thus highly
consistent.
Figure 2. Screening of anti-influenza phytochemicals using a PA endonuclease-inhibition assay. Screening of phytochemicals for anti-
influenza A activity using a PA endonuclease assay. The effects of the various phytochemicals upon the endonuclease activity of the PA N-terminal
domain of the influenza A RNA polymerase were tested. The recombinant PA N-terminal domain protein was added to each reaction at 0.35 mg/
100 ml. A zero control (no PA domain added) was also assayed. Phytochemicals were added at a 1 or 10 mM dose and M13mp18 was used as the
substrate.
doi:10.1371/journal.pone.0019825.g002
Anti-Influenza Activity of Cyclic Bisbibenzyls
PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e19825Comparisons between marchantin and other inhibitors
of influenza A
To determine whether a common active chemical group is
contained among inhibitors of the influenza virus, we compared
marchantin with other influenza and PA endonuclease inhibitors.
Previously, we have reported that the green tea catechins,
epigallocatechin gallate (EGCG) and epicatechin gallate (ECG)
[38,39] have these inhibitory properties [17] (Fig. 7). We have
also reported that several synthesized phthalimide chemicals,
namely N-{2-[2-(3,4-dihydroxyphenyl)ethyl]phenyl}phthalimide
and N-{3-[2-(3,4-dihydroxyphenyl)ethyl]phenyl}phthalimide also
inhibit PA endonuclease and have anti-influenza activity [29]
Figure 3. Docking simulation of marchantin E with influenza PA endonuclease. A) Docking simulation analysis of marchantin E with the PA
endonuclease domain of the influenza A RNA polymerase. PA endonuclease is depicted as a ribbon structure. The a-helix and b-strands are shown in
red and yellow, respectively. Manganese ions in the PA endonuclease are shown as cyan. Marchantin E is shown as a stick structure with oxygen
atoms indicated in red. B) The fitting of marchantin E to the active pocket of the PA endonuclease. Marchantin E is displayed in a sphere mode. The
surface of the pocket of the PA endonuclease is indicated in green and purple. The grey and red balls indicate carbon and oxygen atoms in
marchantin E, respectively. C) Two dimensional analysis of the interaction between marchantin E and PA endonuclease. The chemical structure of
marchantin E is shown in the center with the key interacting amino acids shown around it. The dihydroxyphenyl group of marchantin E interacts with
two manganese ions. The hydroxy groups of marchantin bind to amino acids in PA endonuclease.
doi:10.1371/journal.pone.0019825.g003
Anti-Influenza Activity of Cyclic Bisbibenzyls
PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e19825(Fig. 7). As marchantins and catechins are natural products,
whereas the phenethylphenylphthalimides are synthetic, their
structures are quite different (Fig. 7). Significantly however, all
contain a dihydroxyphenethyl group (Fig. 7), again confirming its
importance in conferring anti-influenza activity. Docking simu-
lation analyses of marchantin A or EGCG with PA endonuclease
showed that both these molecules chelate divalent manganese
ions within PA endonuclease via dihydroxy groups (Fig. 8). These
simulation analyses further underlie the importance of the
dihydroxyphenethyl groups that are common to anti-influenza
chemicals.
Discussion
This is the first report to show that secondary metabolites from
liverworts have anti-influenza activity. Marchantin has a unique
macrocyclic structure, and is therefore a novel type of anti-
influenza chemical. Whilst marchantin targets PA endonuclease,
oseltamivir does so for neuraminidase. We speculated that a
combination of marchantin and oseltamivir would be effective
against influenza, because it can inhibit two independent steps that
are essential for the growth of this virus. We believe therefore that
a marchantin solution or a liverwort extract would likely be an
efficient gargle for the prevention of influenza.
As shown in Figures 3c and 8, the amino acids in PA that are
importantfordockingwithmarchantin AorEarecommon(alsosee
Fig. 8). We speculate that the small differences in the docking mode
between marchantin A and E that we observed may be due to the
methoxy group of marchantin E. Based on our present analyses, we
propose a ‘‘fitting and chelating model’’ as the mechanism by which
Figure 4. Anti-influenza activity of marchantins. Inhibition of the
growth of influenza A or B viral by phytochemicals. MDCK cells were
treated with influenza A/Hiroshima/52/2006 (H3N2) (A), A/Solomon/3/
2006 (H1N1) (B) or B/Malaysia/2506/2004 (C) viruses. The cells were
then treated with various concentrations of phytochemicals (6.25–
50 mM), some of which suppressed viral-induced cell death. DMSO was
used as the phytochemical solvent.
doi:10.1371/journal.pone.0019825.g004
Table 1. Specific activity of marchantins against viral
infectivity titer.
Chemicals Conc. (mM) Log (Focus formation unit/ml)
Dihydroxy
phenethyl
group
24 (hr) 48 (hr) 72 (hr)
MA 50 2.7 4.04 4.9 +
13 2.85 4.62 5.16
3.1 2.78 4.64 5.87
MAt 50 2.7 4.24 5.12 -
13 2.85 4.86 5.22
3.1 2.9 4.5 5.97
ME 50 2.7 4.3 4.64 +
13 2.7 4.59 5.1
3.1 3.04 4.6 5.71
RA 50 2.7 4.25 5.19 -
13 2.9 4.9 5.1
3.1 3.04 4.65 5.88
PlA 50 2.9 4.27 4.97 +
13 2.95 4.95 5.13
3.1 2.85 4.96 5.72
PeF 50 2.9 4.15 4.85 +
13 2.7 4.51 5.12
3.1 2.6 4.7 5.92
DMSO
(solvent)
50 2.9 4.5 5.82
13 2.78 4.73 5.79
3.1 2.6 4.64 6
Negative
control
- 2.9 5.15 5.89
doi:10.1371/journal.pone.0019825.t001
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endonuclease. These data thus represent an important advance for
future strategies to refine marchantin-based drug design using an in
silico binding simulation with PA. Our structure-function relation-
ship analysis and docking simulation analysis also provide valuable
new information for the design of novel anti-influenza drugs.
Materials and Methods
Purification of phytochemicals
Marchantins were isolated from the methanol extracts of
Marchantia polymorpha and M. paleacea var. diptera [19,24], perrottetin
Ff r o mPlagiochila sciophila, and plagiochin A from Radula kojana.
Figure 5. Decrease of the viral infectivity titer by marchantins. Decrease of viral infectivity titer of influenza B viral by phytochemicals. MDCK
cells were treated with influenza B/Malashia/2506/2004 virus. The cells were then treated with various concentrations of phytochemicals (3.1–50 mM),
some of which decreased viral infectivity titer. DMSO was used as the phytochemicals solvent. (A) Viral growth curve under exposure to various
concentrations of marchantins. The horizontal axis is the culture time and the vertical axis is the logarithm of virus infectivity titer (focus formation
unit (FFU)). (B) Viral growth curve in the presence of marchantins and comparisons of the same concentration. The horizontal axis is the culture time
and the vertical axis is the logarithm of virus infectivity titer (focus formation unit (FFU)).
doi:10.1371/journal.pone.0019825.g005
Figure 6. Docking amino acids are conserved between influenza A and B. The docking amino acids (Glu23, His41, Glu80, Arg84, Asp108,
Glu119 and Lys134) identified in Figure 3 are shown in an alignment of influenza A and B amino acid sequences. This alignment was generated using
the clustal X program.
doi:10.1371/journal.pone.0019825.g006
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tetraen-3-one were isolated from the fungus Daldinia concentrica
[40,41]. 5, 6-Dehydrokawain, kawain, dihydrokawain, methysticin
and yangonin were isolated from Fijian Kawa (Piper methysticum)[ 4 2 ] .
Osumundalactone was isolated from the fungus Paxillus atromentosus
[43]. 8-Methoxypsoralen, 5-methoxypsoralen, isopimpinellin, osthol
and imperatprin were isolated from the fruits of Cnidium monnieri,
belonging to the Umbelliferae. Phellopterin, isoimperatorin and
heraclenin (also known as pragenin) were isolated from the root of
Angelica dahurica, also belonging to the Umbelliferae. Magnolol and
honokiol were isolated from the bark of the Magnolia obovata belonging
to the Magnoliaceae. Lycogarbins A and B were isolated from the
slime molds (Myxomycete) Lycogala epidendrum [44].
Expression and purification of the PA endonuclease
domain
The influenza (A/PR/8/34) H1N1 RNA polymerase PA
plasmid, pBMSA-PA, was sourced from the DNA Bank, Riken
BioResource Center (Tsukuba, Japan; originally deposited by Dr.
Susumu Nakada) [45]. The cDNA fragment corresponding to the
PA N-terminal endonuclease domain (residues 1–220) was
amplified by PCR [46] from pBMSA-PA using the primers PA
endonuclease forward NdeI, GCC GTT CAT ATG GAA GAT
TTT GTG CGA CAA and PA endonuclease reverse BamHI,
GCC GTT GGA TCC TAT TGG TCG GCA AGC TTG CG.
The amplified product was then subcloned into the pET28a(+)
plasmid (Novagen, Madison, WI) at the NdeI and BamHI
restriction sites. The resulting construct was then introduced into
BL21-CodonPlus E. coli cells (Stratagene, La Jolla, CA). The
induction of 6x his-tagged recombinant protein expression from
these constructs was achieved by the addition of isopropyl -D-
thiogalactopyranoside (IPTG) [47] to the bacterial cultures in
TBG-M9 medium and this was followed by purification using
Ni
2+-agarose [48]. The recombinant PA endonuclease domain
protein was further purified to near homogeneity using a
HiTrap
TM Q FF column (GE Healthcare, Buckinghamshire,
UK) with the AKTA
TM prime plus system (GE Healthcare).
PA endonuclease activity assay
Influenza A RNA polymerase PA endonuclease activity assays
were performed essentially as described by Dias et al. [14–16] with
some modifications. Briefly, the pH conditions were modified from
8.0 to 7.3 and 1 mg of M13mp18 single stranded circular phage
DNA was used as the assay substrate. A total of 0.35 mgo f
recombinant PA endonuclease domain was added to 100 mlo f
assay buffer in each reaction (the final concentration of the protein
was about 0.1 mM). Phytochemicals (summarized in Fig. 1) were
then added to the reaction and products were analyzed by agarose
electrophoresis and stained with ethidium bromide.
Inhibition of viral growth
Madin-Darby canine kidney (MDCK) cells [34] were cultured
in MEM (minimum essential medium; Gibco/Invitrogen, Carls-
bad, CA) supplemented with 10% fetal bovine serum in a 5% CO2
incubator at 37 uC. A confluent monolayer of MDCK cells was
prepared in each well of a 96 well plate. Various concentrations
(6.25–50 mM) of phytochemicals were then mixed with TCID50
(fifty-percent of the infectious dose) of A/Hiroshima/52/2006
(H3N2), A/Solomon/3/2006 (H1N1) or B/Malashia/2506/2004
influenza strains and incubated at 37uC for 30 min [35]. The
MDCK cells were then washed with PBS(-) and the viral mixture
was added to the cells. Treated cells were then incubated for four
days at 34 ˚C under 5% CO2. After incubation, the medium was
removed and cells were fixed with a 10% formaldehyde solution.
Viable cells were stained with NB solution (0.1% napthol blue
black, 0.1% sodium acetate and 9% acetic acid) [35].
Focus-formation assay
MDCK cells were incubated on micro plates (24-well) at 37˚C
for three days in a CO2 incubator. The cells were washed with
PBS(-) and influenza virus (B/Malaysia/2506/2004) solution was
Figure 7. Consensus structure of chemicals with anti-influenza
activity. Consensus structure of the phytochemicals and synthesized
chemicals possessing anti-influenza A activity. The dihydroxyphenethyl
group (shown as red) is common to marchantin, catechin and several
phthalimide molecules which all inhibit the influenza virus.
doi:10.1371/journal.pone.0019825.g007
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˚C for 30 min and the cells were washed by PBS(-) to remove
unabsorbed virus. Concentrations of 50, 12.5 or 3.1 mMo f
chemicals in growth medium were added into each well. The cells
were then incubated at 37 ˚C for three days and a portion of the
supernatant was sampled each day. The sampled supernatants
were subjected to a focus forming unit (FFU) assay using the PAP
(rabbit peroxidase anti-peroxidase) method. Fresh MDCK cells
were incubated in micro plates (96-well) at 37 ˚C for three days.
The obtained virus solutions were 10-fold titrated in micro plates
(from 10 to 10
8 times). The cells were then washed with PBS(-)
and 100 ml of the titrated virus solutions was added to the cells.
Viruses were absorbed on the cells at 37 ˚C for 60 min with
shaking at 15 min intervals. The cells were washed with PBS(-) to
remove unabsorbed virus and MEM medium (serum (-)) was then
added, followed by an incubation at 37˚C for 1 day. Supernatant
was removed and cells were fixed with ethanol for 10 min at
room temperature. The ethanol was then removed and cells were
dried.
The staining of foci via the PAP method was performed as
follows: 50 ml of a 1000 fold-dilution of the primary antibody
(mouse anti-influenza A or B NP serum) was added to each well
and incubated at 37˚C for 30 min. Each well was washed with
PBS(-). 50 ml of a 1:1000 dilution of secondary antibody (rabbit
anti-mouse IgG serum) was then added into each well and
incubated at 37˚C for 30 min. Each well was further washed in
PBS(-). 50 ml of a 1:500 dilution of a third antibody (goat anti-
rabbit IgG serum) was next added into each well and the cells were
treated as before. Finally, 50 ml of a 1:10000 PAP complex
solution was added to each well and incubated at 37 ˚C for 30 min.
Each well was washed by PBS(-). This was followed by the addition
of 50 ml of substrate (3,39-diaminobenzidin tetrahydrochloride) for
10–15 min at room temperature, washing with water and drying.
The infectivity titer (FFU) was calculated by counting the numbers
of foci i.e. numbers of foci per well x titration of virus solution x
1000 / 100 (volume of virus solution)=infectivity titer (FFU/ml).
In silico docking simulation analyses of marchantins and
catechin with the PA endonuclease domain of influenza
A
All molecular modeling studies were performed using Molecular
Operating Environment (MOE; Chemical Computing Group,
Quebec, Canada) software [31–33]. The X-ray crystallographic
structure of the endonuclease domain of PA subunit of influenza A
virus RNA dependent RNA polymerase (PDB ID: 3HW5) was
obtained from a protein data bank [30]. This enzyme was
prepared for docking studies in which (i) the ligand molecule was
removed from the enzyme active site; (ii) hydrogen atoms were
added to the structure with a standard geometry; (iii) the structure
was minimized using a MMFF94s force-field; (iv) MOE Alpha Site
Finder was used for active site searches within the enzyme
structure and dummy atoms were created from the obtained alpha
spheres; and (v) the obtained model was then used in the ASEDock
program (Ryoka Systems Inc., Tokyo, Japan). A total of 250
conformations of marchantin A or E were generated by Low
Mode MD. The used parameters in step 1 were as follows: cut off
value, 4.5; RMS gradient, 10; and energy threshold, 500. The
used parameters in step 2 (optimization) were as follows: cut off
value,8; RMS gradient, 0.1.
Supporting Information
Table S1 Effect of marchantins on viral infectivity titer
(raw data). We tested the effects of marchantins on viral
infectivity-titer and counted the viral foci along with time course.
This raw data are calculated and summarized in Table 1 and
presented as graphs in Figure 5.
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